Infectious Disease Diagnostics Market 2025 Global Forecasts by Top Players - Trinity Biotech, Cardinal Health, bioMérieux, Bio-Rad Laboratories, AccuBioTech, ACON Laboratories

"Global Infectious Disease Diagnostics Market Analysis to 2025" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global infectious disease diagnostics market with detailed market segmentation by product, disease indication, technology, test location, end user and geography.

Infectious Disease Diagnostics Market to 2025 - Global Analysis and Forecasts Product (Kits & Reagents and Instruments), Disease Indication [HIV, Hepatitis, Healthcare Associated Infections (HAIs), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, and Others], Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, and Others), Test Location (Laboratory Testing and Point of Care Testing), End User (Hospitals, Pathology/Diagnostic Laboratories, Research Institutes, Home-Care Settings, and Others) and Geography

The growth of global infectious disease diagnostics market is expected to be driven by various factors such as increasing prevalence of infectious and vector-borne diseases, and advances in molecular and immunodiagnostics is expected to propel the growth of the global infectious disease diagnostics market.

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPHE100001430

Infectious Disease Diagnostics market report also includes the profiles of leading infectious disease diagnostics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key developments in past five years.

1 Danaher
2 Abbott
3 BD
4 F. Hoffmann-La Roche Ltd
5 Trinity Biotech
6 Cardinal Health
7 bioMérieux SA
8 Bio-Rad Laboratories, Inc.
9 AccuBioTech Co., Ltd.
10 ACON Laboratories, Inc.

The growth of global infectious disease diagnostics market is expected to be driven by various factors such as increasing prevalence of infectious and vector-borne diseases, and advances in molecular and immunodiagnostics is expected to propel the growth of the global infectious disease diagnostics market. However, absence of compiled regulatory guidelines and lack of centralized laboratory facilities in developing and under-developed laboratories are expected to hinder the market growth at certain extent. On the other hand, the immunodiagnostic kits and home-based point-of-care diagnostic tools for detection of various diseases is expected to be one of the most prevalent trend in the infectious disease diagnostics market.

Have Queries? Ask us at https://www.theinsightpartners.com/inquiry/TIPHE100001430

North America holds a dominant position in the global infectious disease diagnostics market. This is primarily attributed to the advancements in the diagnostic tools and technologies, increasing prevalence of infectious diseases, and presence of highly developed healthcare infrastructure in this region. Asia Pacific on the other hand is expected to witness significant traction over the forecast period owing to the development of novel diagnostic products at affordable costs. The emerging economies in Asia Pacific such as India and China are expected to be the primary consumers of the diagnostic tests owing to lack of awareness regarding sanitation and hygiene in these countries leading to incidence of infectious diseases.

The global infectious disease diagnostics market is segmented on the basis of product, disease indication, technology, test location, end user. On the basis of product, the global infectious disease diagnostics market is segmented into reagents & kits and instruments. Based on disease indication, the market is segmented into HIV, hepatitis, healthcare associated infections (HIAs), human papillomavirus (HPV), tuberculosis, influenza, and others. Based on the technology, the market is segmented into immunodiagnostics, polymerase chain reaction (PCR), next generation sequencing (NGS), and others. On the basis of test location, the global infectious disease diagnostics market is segmented in to laboratory testing and point-of-care testing. Similarly, on the basis of end user, the global infectious disease diagnostics market is segmented in to hospitals, pathology/diagnostic laboratories, research institutes, home care settings and others.

The infectious disease diagnostics market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global infectious disease diagnostics market based on technology, disease indication and end user. It also provides market size and forecast till 2025 for overall infectious disease diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

Buy this Report at https://www.theinsightpartners.com/buy/TIPHE100001430

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us -
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com

This release was published on openPR.